KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD) is challenging in clinical practice due to the poor understanding of molecular mechanisms and limited therapeutic targets. Herein, the work aimed to use bioinformatics to identify a promising molecular target for LUAD therapy. METHODS: Differentially expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaodong, Yu, Bingxin, Qi, Fangyuan, Li, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103954/
https://www.ncbi.nlm.nih.gov/pubmed/33968780
http://dx.doi.org/10.3389/fonc.2021.670218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103954/
https://www.ncbi.nlm.nih.gov/pubmed/33968780
http://dx.doi.org/10.3389/fonc.2021.670218

Ejemplares similares